Denmark· DK-28103707704

Alvesco

A ciclesonide product containing ciclesonid, registered in Denmark by Covis Pharma Europe B.V.. The same ATC class is registered in 15 of our 19 countries.

ATC R03BA08

Checked against Danish Medicines Agency (Denmark) on

Informational only — not a medical device.

SOURCE REGISTER · DKDanish Medicines Agency (Denmark)normalisedAlvescoATCR03BA08REGISTER NO.DK-28103707704PACKS LISTED1CHECKEDSeptember 30, 2026

Where it is registered

Ciclesonide is registered in 15 of 19 countries.

Countries holding a registration under ATC R03BA08 (ciclesonide), each read from that country’s own register.

  • This record: Denmark, from Danish Medicines Agency (Denmark)
  • 8 of them publish a price we can compare per daily dose

Ciclesonide · ATC R03BA08

15 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Germany
  • Ireland
  • Italyprice
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Danish Medicines Agency (Denmark)
Active substance
CICLESONID
Manufacturer
Covis Pharma Europe B.V.
Country
Denmark (DK)
ATC code
R03BA08
ATC class
Ciclesonide
Defined daily dose
0.16 mg, Inhal
Reimbursed
Not published by this register
Source register
Danish Medicines Agency (Denmark)
Last checked
September 30, 2026

Packs & prices · 1

  • dk_varenummer
    28103707704

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

77 interactions on record for ciclesonide.

Graded by severity as the source publishes them — 5 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Ciclesonide · interactions on record

77 records

  • 5 severe
  • 42 moderate
  • 19 minor
  • 11 info

Most severe, free to view

  • DesmopressinH01BA02severe
  • CladribineL01BB04severe
  • Dinutuximab betaL01FX06severe
  • Brexucabtagene autoleucelL01XL06severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Danish Medicines Agency (Denmark). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/f0d3f300-6851-4ec6-a782-bf721377522d
GET /v1/drugs/f0d3f300-6851-4ec6-a782-bf721377522d?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "inhalationsspray, opløsning",
  "source": "dkma",
  "strength": "80 mikrogram/dosis",
  "auth_role": "CMS",
  "dk_drugid": "28103707704",
  "substance": "CICLESONID",
  "auth_procedure": "MRP",
  "in_medicinpriser": true,
  "registration_date_serial": "38376"
}

See everything about ciclesonide.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.